EA201992048A1 - Новый вязкоупругий раствор и его применение в ревматологии - Google Patents

Новый вязкоупругий раствор и его применение в ревматологии

Info

Publication number
EA201992048A1
EA201992048A1 EA201992048A EA201992048A EA201992048A1 EA 201992048 A1 EA201992048 A1 EA 201992048A1 EA 201992048 A EA201992048 A EA 201992048A EA 201992048 A EA201992048 A EA 201992048A EA 201992048 A1 EA201992048 A1 EA 201992048A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rheumatology
sulfate
application
viscoelastic solution
keratan
Prior art date
Application number
EA201992048A
Other languages
English (en)
Other versions
EA039339B1 (ru
Inventor
Патрик Сак-Эпе
Ален Шуфт
Тьерри Конрозье
Original Assignee
Лаборатуар Де Рюматоложи Апплике
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Де Рюматоложи Апплике filed Critical Лаборатуар Де Рюматоложи Апплике
Publication of EA201992048A1 publication Critical patent/EA201992048A1/ru
Publication of EA039339B1 publication Critical patent/EA039339B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к вязкоупругому раствору, содержащему полисахарид, выбранный из гиалуроновой кислоты, хондроитинсульфата, кератана, кератансульфата, дерматансульфата, гепарина, гепарансульфата, хитозана, ксантанов, альгинатов и каррагинанов либо одной из их солей; и антифибринолитическое средство, выбранное из транексамовой кислоты, эпсилон-аминокапроновой кислоты, протамина и десмопрессина; и его применению в ревматологии.
EA201992048A 2017-03-07 2018-03-06 Вязкоупругий раствор и его применение в вискосапплементарной терапии EA039339B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1751823A FR3063649B1 (fr) 2017-03-07 2017-03-07 Nouvelle solution visco-elastique et son utilisation en rhumatologie
PCT/FR2018/050499 WO2018162830A1 (fr) 2017-03-07 2018-03-06 Nouvelle solution visco-élastique et son utilisation en rhumatologie

Publications (2)

Publication Number Publication Date
EA201992048A1 true EA201992048A1 (ru) 2020-01-28
EA039339B1 EA039339B1 (ru) 2022-01-14

Family

ID=58779168

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992048A EA039339B1 (ru) 2017-03-07 2018-03-06 Вязкоупругий раствор и его применение в вискосапплементарной терапии

Country Status (8)

Country Link
US (1) US11135189B2 (ru)
EP (1) EP3592332B1 (ru)
JP (1) JP7093372B2 (ru)
CN (1) CN110461308A (ru)
EA (1) EA039339B1 (ru)
ES (1) ES2951115T3 (ru)
FR (1) FR3063649B1 (ru)
WO (1) WO2018162830A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102566287B1 (ko) * 2018-11-30 2023-08-11 주식회사 엘지화학 히알루론산을 포함하는 활액보충재용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2604643B2 (ja) * 1990-11-30 1997-04-30 株式会社資生堂 皮膚外用剤組成物
RU2128030C1 (ru) * 1998-01-20 1999-03-27 Закрытое акционерное общество Екатеринбургский центр МНТК "Микрохирургия глаза" Вискоэластичный препарат "визикап"
US6186148B1 (en) * 1998-02-04 2001-02-13 Kiyoshi Okada Prevention of posterior capsular opacification
JPH11279205A (ja) * 1998-03-26 1999-10-12 Nippon Tenganyaku Kenkyusho:Kk ヒアルロン酸類製剤の分解抑制方法
JP4716497B2 (ja) * 2005-08-09 2011-07-06 株式会社 資生堂 皮膚外用剤およびヒアルロニダーゼ阻害剤
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
KR101823036B1 (ko) * 2010-03-31 2018-01-31 (주)아모레퍼시픽 멜라닌 색소 생성 억제제 및 이를 함유하는 화장료 조성물
KR20160129108A (ko) * 2011-04-15 2016-11-08 가톨릭대학교 산학협력단 결합조직 재생용 조성물 및 결합조직을 재생하는 방법
WO2012176865A1 (ja) * 2011-06-23 2012-12-27 参天製薬株式会社 ヒアルロン酸またはその塩およびプロピレングリコールを含有する点眼液
JP2016506909A (ja) * 2013-01-11 2016-03-07 カービラン セラピューティクス， インコーポレイテッド ヒアルロン酸を含む安定化組成物
JP6403487B2 (ja) * 2014-08-12 2018-10-10 ロート製薬株式会社 外用剤

Also Published As

Publication number Publication date
WO2018162830A1 (fr) 2018-09-13
EP3592332A1 (fr) 2020-01-15
EP3592332C0 (fr) 2023-06-07
EA039339B1 (ru) 2022-01-14
CN110461308A (zh) 2019-11-15
JP7093372B2 (ja) 2022-06-29
US11135189B2 (en) 2021-10-05
FR3063649B1 (fr) 2021-05-21
JP2020510088A (ja) 2020-04-02
EP3592332B1 (fr) 2023-06-07
US20200000754A1 (en) 2020-01-02
FR3063649A1 (fr) 2018-09-14
ES2951115T3 (es) 2023-10-18

Similar Documents

Publication Publication Date Title
MA55627A (fr) Agonistes de glp-1r et leurs utilisations
EP2540284A3 (en) Compositions and methods for stabilized polysaccaride formulations
WO2019075263A3 (en) Methods and compositions for topical delivery
CY1124054T1 (el) Τεχνητα δακρυα που περιεχουν υαλουρονικο νατριο και καρβοξυμεθυλοκυτταρινη
MX2016014050A (es) Combinacion de un acido hialuronico y un polisacarido sulfatado.
PH12014501387A1 (en) Low anticoagulant heparins
EA201790856A1 (ru) Новый сульфат декстрана
BR112015012198A2 (pt) método de preparação de fibras à base do derivado c11-c18 acilatado de hialuronano nos grupos hidroxila do ácido hialurônico, fibra baseada no derivado c11-c18 acilatado de hialuronano nos grupos hidroxila do ácido hialurônico, uso da fibra, têxtil e uso dos têxteis à base das fibras
DK2794665T3 (da) Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
BR112015001129A2 (pt) resinas com resistência a úmido de alta eficácia provenientes de novos reticuladores
BR112019002290A2 (pt) um novo hidrogel feito de glicosaminoglicanos reticulados duplos, particularmente ácido hialurônico reticulado, condroitina ou sulfato de condroitina, com ligações reversíveis usando ácido borônico ou derivados de boroxol levando a novos benefícios. glicosaminoglicanos reticulados duplos, uma ligação por meio de duas uniões de éter com um grupo hidroxila de cada dos dois glicosaminoglicanos e outra ligação por meio de um ânion de éster alcoxiboronato formado entre um hemiéster de boronato enxertado a um dos glicosaminoglicanos e uma função diol de ao outro glicosaminoglicano. a função diol pode ser uma função diol de cadeia principal ou uma porção diol de uma fração funcional diol enxertada ao outro glicosaminoglicano.
BR112016005288A2 (pt) Polímero de álcool vinílico, agente espessante, estabilizador para polimerização em emulsão, estabilizador para polimerização em suspensão, agente de revestimento, artigo revestido, agente de colagem para fibras, fios colados e método para produzir tecido
BR112017017861A2 (pt) ?processos para limpeza de superfícies metálicas sujas e para preparação de uma polietilenimina alcoxilada, polietilenimina alcoxilada, composição aquosa, e, uso de pelo menos uma polietilenimina alcoxilada?.
WO2011082175A3 (en) Glycosaminoglycan inhibitors
EA201992048A1 (ru) Новый вязкоупругий раствор и его применение в ревматологии
MX2013011186A (es) Hebras de fibra de vidrio y rpoductos reforzados que comprenden las mismas.
TW200704403A (en) Dilution resistant viscoelastic compositions
IN2013MU03773A (ru)
FR3064474B1 (fr) Nouvel ingredient protecteur et/ou reparateur des phaneres
SG11202005518XA (en) Heparin and heparan sulphate oligosaccharides
BR112016001826A2 (pt) Composição compreendendo um aminossilicone, um tensoativo catiônico, um polímero associativo e um agente espessante
HK1203377A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
PL391043A1 (pl) Zastosowanie modyfikowanych polisacharydów do neutralizacji heparyny
BR112016001828B8 (pt) composição compreendendo um aminossilicone, um tensoativo catiônico e um polímero associativo catiônico
EP3808353C0 (en) COMPOSITION AND USE OF AN OPHTHALMIC SOLUTION BASED ON HYALURONIC ACID AND ARABINOGALACTAN